CD5(+) small B-cell neoplasms of indeterminate immunophenotype: A clinicopathologic analysis of 28 cases.

被引：0
|
作者：
Asplund, SL [1 ]
McKenna, RW [1 ]
Kroft, SH [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
910
引用
收藏
页码：155A / 155A
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of aberrant CD5 expression in B-cell leukemia
    Jaseb, Kaveh
    Purrahman, Daryush
    Shahrabi, Saeid
    Ghanavat, Majid
    Rezaeean, Hadi
    Saki, Najmaldin
    ONCOLOGY REVIEWS, 2019, 13 (01) : 77 - 82
  • [22] CD5 EXPRESSION IN B-CELL SMALL LYMPHOCYTIC MALIGNANCIES - CORRELATIONS WITH CLINICAL PRESENTATION AND SITES OF DISEASE
    SUNDEEN, JT
    LONGO, DL
    JAFFE, ES
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (02) : 130 - 137
  • [23] Low-grade B-cell lymphoma with coexpression of both CD5 and CD10 - A report of 3 cases
    Barekman, CL
    Aguilera, NSI
    Abbondanzo, SL
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (07) : 951 - 953
  • [24] CD5 EXPRESSION IS MODULATED AS THE B-CELL MOVES THROUGH THE CELL-CYCLE
    BROOKS, KH
    YOL, YS
    PESTKA, JJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 259 - 260
  • [25] Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL): a clinicopathologic study of 17 cases.
    Hembury, T
    Lee, B
    Gascoyne, RD
    Macpherson, N
    House, N
    Medeiros, LJ
    Hsi, ED
    LABORATORY INVESTIGATION, 2001, 81 (01) : 166A - 166A
  • [26] Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup:: Development of a CD5 signature
    Suguro, Miyuki
    Tagawa, Hiroyuki
    Kagami, Yoshitoyo
    Okamoto, Masataka
    Ohshima, Koichi
    Shiku, Hiroshi
    Morishima, Yasuo
    Nakamura, Shigeo
    Seto, Masao
    CANCER SCIENCE, 2006, 97 (09) : 868 - 874
  • [27] Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL): a clinicopathologic study of 17 cases.
    Hembury, T
    Lee, B
    Gascoyne, RD
    Macpherson, N
    House, N
    Medeiros, LJ
    Hsi, ED
    MODERN PATHOLOGY, 2001, 14 (01) : 166A - 166A
  • [28] CD5 ANTIGEN EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    BROHEE, D
    CAUCHIE, P
    NEVE, P
    MEDICAL SCIENCE RESEARCH, 1994, 22 (08): : 561 - 562
  • [29] B-Lymphoblastic Leukemia With Aberrant CD5 Expression: Clinicopathologic Features and Outcome in 10 Cases
    Ye, Matthew T.
    Zhu, Jia
    Luo, David X.
    Wang, Yi
    Chen, Zehui
    Yang, Yaling
    Tian, Chen
    Zhang, Yizhuo
    You, M. James
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (04) : 586 - 595
  • [30] THE T/B-CELL ANTIGEN, CD5, AND THE B-CELL SURFACE PROTEIN, CD72, FORM A PAIR OF INTERACTING RECEPTORS
    VANDEVELDE, H
    VONHOEGEN, L
    WEI, L
    PARNES, JR
    THIELEMANS, K
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 443 - 452
12345